Records containing: Idiopathic Pulmonary Fibrosis (IPF)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-09-15Radiologic Features of Patients With Rheumatoid Arthritis Related Interstitial Lung Disease at Chest High Resolution Computed Tomography
-
CLINICAL_TRIALS study record update · 2025-09-09Idiopathic Pulmonary Fibrosis Cohort Studies of Chinese Medicine
-
CLINICAL_TRIALS study record update · 2025-08-20A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-08-06A Phase 1b, Open-label Study of PIPE-791 to Determine Brain and Lung Lysophosphatidic Acid Receptor 1 (LPA1) Occupancy, by [18F] PIPE-497 PET Imaging in Healthy Volunteers, Volunteers With Progressive Multiple Sclerosis, and Volunteers With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-06-13An Open-label Extension Trial of the Long-term Safety and Efficacy of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-16Effects of Downhill Walking in Pulmonary Rehabilitation for Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-04-22Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study
-
CLINICAL_TRIALS study record update · 2025-04-03D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis
-
CLINICAL_TRIALS study record update · 2025-03-25Idiopathic Pulmonary Fibrosis, a Disease Initiated by Mucociliary Dysfunction
-
CLINICAL_TRIALS study record update · 2025-03-19A Multi-center, Phase Ib/IIa Clinical Trial to Evaluate the Tolerability, PK and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-11-14Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-10-21Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findingsin Patients With Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-05-22A Randomized, 52 Week, Double-blind, Multicentre, Parallel, Placebo-controlled Phase 2b Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Investigating the Efficacy and Safety of GB0139, an Inhaled Galectin-3 Inhibitor.
-
CLINICAL_TRIALS study record update · 2023-07-07Pulmonary Fibrosis Foundation Patient Registry
-
CLINICAL_TRIALS study record update · 2023-03-07An Open-Label Study to Evaluate the Safety, Tolerability, Kinetics, and Repeatability of the Novel Lysophosphatidic Acid Receptor 1 (LPA1) Positron Emission Tomography (PET) Ligand 18F-BMS-986327
-
CLINICAL_TRIALS study record update · 2022-06-10A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 2-Period, 2-Arm, 4-Sequence, Crossover Phase 1b Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ang-3070 in Subjects With Idiopathic Pulmonary Fibrosis Who Are Treatment-Naïve or Who Have Failed or Refused Standard of Care Treatment
-
CLINICAL_TRIALS study record update · 2022-02-23A Ph 1, Rndmzd, Dbl-Blinded, Pbo-Controlled, 4-Part Study to Eval the Safety, Tolerability, PK, and PD of TD-1058 Admin by Inhalation of Single (A) and Multiple (B) Ascending Doses in Healthy Subjs and Subjs With IPF (C) and Following Admin Microtracer Doses (D)
-
CLINICAL_TRIALS study record update · 2021-06-08Pilot Study to Evaluate Inhaled N-Acetylcysteine in Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2021-03-09A Phase I, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2020-09-02A Phase I Study to Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its Pharmacokinetic Profile in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-08-04Determining the Effectiveness of Nebulized Morphine in Treating Dyspnea in Advanced Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2020-07-31Prospective, Longitudinal Cohort Trial of Patients With Idiopathic Pulmonary Fibrosis (IPF) and Healthy Control Patients. Clinical Data, Blood, and Bronchiolavage (BAL) Fluid Will be Collected Over 12 Months.
-
CLINICAL_TRIALS study record update · 2020-05-15An Open Label Study to Assess the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 Following a Single Oral Dose Administration in Healthy Participants
-
CLINICAL_TRIALS study record update · 2020-05-12Targeted Removal of Pro-Inflammatory Cells: An Open Label Human Pilot Study in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2020-02-28Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Dose-Escalation Study of STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)